Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Antibody Response after One and/or Two Doses of BNT162b2 Anti- Sars-Cov-2 mRNA Vaccine in Patients Treated By CAR T-Cells Therapy

Blood (2021) 138 (Supplement 1): 254.

https://doi.org/10.1182/blood-2021-149476

Published: 2021

Journal Articles

Sars-Cov-2 T-Cell Response in Allogeneic Hematopoietic Stem Cell Recipients Following Two Doses of BNT162b2 Vaccine

Blood (2021) 138 (Supplement 1): 2895.

https://doi.org/10.1182/blood-2021-149139

Published: 2021

Journal Articles

Interest of a Third Dose of BNT162b2 Anti- Sars-Cov-2 mRNA Vaccine in Allogeneic Hematopoietic Stem-Cells Recipients

Blood (2021) 138 (Supplement 1): 3908.

https://doi.org/10.1182/blood-2021-149178

Published: 2021

Journal Articles

Profound B-Cell Lymphopenia Is a Major Factor Predicting Poor Humoral Response after BNT162b2 mRNA Sars-Cov-2 Vaccines in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2021) 138 (Supplement 1): 3911.

https://doi.org/10.1182/blood-2021-150439

Published: 2021

Journal Articles

Prognostic Value of Lymphopenia and Lymphocytosis after Peripheral Blood Haplo-Identical Stem Cell Transplantation

Yannick LE Bris, PharmD, Thierry Guillaume, MD PhD, Camille Debord, PharmD, Pierre Peterlin, Soraya Wuilleme, PharmD, PhD, Céline Bressollette, MD PhD, Amandine Le Bourgeois, MD, Alice Garnier, MD, Aurélie Fantou, PharmD, Marie Audrain, MD PhD, Audrey Ménard, Nelly Robillard, PhD, Marion Eveillard, Steven Le Gouill, Berthe Marie Imbert, PharmD, PhD, Marie C Bene, PharmSciD, PhD, Patrice Chevallier, MD

Blood (2019) 134 (Supplement_1): 3319.

https://doi.org/10.1182/blood-2019-122093

Published: 2019

Journal Articles

Post-Transplant Cyclophosphamide (PTCY) Versus Anti-Thymoglobulin (ATG) As Part of the Gvhd Prophylaxis for Fludarabine/Clofarabine/Busulfan Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT): Influence on Early Outcomes

Alice Garnier, MD, Thierry Guillaume, MD, Pierre Peterlin, MD, Beatrice Mahe, MD, Viviane Dubruille, MD, Nicolas Blin, MD, Maud Voldoire, MD, Thomas Gastinne, MD, Cyrille Touzeau, MD PhD, Steven Le Gouill, MD PhD, Yannick Le Bris, PharmD, Marion Eveillard, PharmD, Marie C Bene, PharmSciD, PhD, Marina Illiaquer, PharmD, Berthe marie Imbert, Philippe Moreau, MD PhD, Patrice Chevallier, MD PhD

Blood (2015) 126 (23): 4339.

https://doi.org/10.1182/blood.V126.23.4339.4339

Published: 2015

Journal Articles

Long-Lasting HHV-6 Reactivation and Immune Recovery In Adult Long-Survivors After Umbilical Cord Blood (UCB) Allo-SCT: A Comparison With PBSC As Stem-Cell Source

Marina Illiaquer, Florent Malard, Thierry Guillaume, MD, Berthe-Marie Imbert-Marcille, Jacques Delaunay, MD, Amandine Le Bourgeois, Marie Rimbert, Céline Bressollette-Bodin, MD, PhD, Cristina Precupanu, MD PhD, Pierre Peterlin, Philippe Moreau, MD, Mohamad Mohty, MD, PhD, Patrice Chevallier, MD, PhD

Blood (2013) 122 (21): 2065.

https://doi.org/10.1182/blood.V122.21.2065.2065

Published: 2013

Journal Articles

Prospective Comparison Of Five Viral Infections (HHV6, CMV, EBV, ADV, BKv) After Umbilical Cord Blood (UCB) Vs PBSC Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation (allo-SCT) In Adults

Marina Illiaquer, PharmD, PhD Student, Berthe-Marie Imbert-Marcille, Pr, Lucie Planche, Marie Rimbert, Claire Le Houerou, Céline Bressollette-Bodin, MD, PhD, Thierry Guillaume, MD, Amandine Le Bourgeois, Jacques Delaunay, MD, Philippe Moreau, MD, Mohamad Mohty, MD, PhD, Patrice Chevallier, MD, PhD

Blood (2013) 122 (21): 3284.

https://doi.org/10.1182/blood.V122.21.3284.3284

Published: 2013

Journal Articles

Higher HHV-6 Reactivation After Cord Blood Allo-SCT Is Not Related to HHV-6 Cell Receptor CD46 Expression

Patrice Chevallier, MD, Nelly Robillard, Marina Illiaquer, Julie Esbelin, Mohamad Mohty, MD PhD, Celine Bodin-Bressollette, Thierry Guillaume, MD, Veronique Stocco, MD, Fabienne Auffray, Sophie Derenne, Lucie Planche, Marie-christine Béné, Berthe-Marie Imbert-Marcille

Blood (2012) 120 (21): 1931.

https://doi.org/10.1182/blood.V120.21.1931.1931

Published: 2012

Journal Articles

A Scoring System Predictive of Extensive Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Stem Cell Transplantation (allo-SCT)

Eolia Brissot, Yohann Foucher, Florent Malard, Zinaida Peric, Aline Clavert, Patrice Chevallier, MD, Thierry Guillaume, Jacques Delaunay, Sameh Ayari, Jean-Luc Harousseau, MD, Philippe Moreau, MD, Marianne Coste-Burel, Berthe-Marie Imbert-Marcille, Marc Gregoire, Cécile Braudeau, Régis Josien, Béatrice Gaugler, Mohamad Mohty

Blood (2011) 118 (21): 1980.

https://doi.org/10.1182/blood.V118.21.1980.1980

Published: 2011

Journal Articles

Epstein Barr Virus (EBV) Reactivation After Reduced Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2010) 116 (21): 1259.

https://doi.org/10.1182/blood.V116.21.1259.1259

Published: 2010

Journal Articles

Epstein Barr Virus (EBV) Reactivation After Reduced Intensity Conditioning (RIC) Unrelated Umbilical Cord Blood Transplantation (UCBT)

Blood (2010) 116 (21): 2334.

https://doi.org/10.1182/blood.V116.21.2334.2334

Published: 2010

Journal Articles

Features of Herpesviruses (CMV, EBV, HHV6) Infections and Immune Reconstitution after Allogeneic Stem Cell Transplantation (allo-SCT) Using Alternative Donors: Comparison Between Matched Unrelated Donors (MUD) and Cord Blood (CB) as Stem Cell Source.

Patrice Chevallier, Thierry Guillaume, Lucie Planche, Imen Hebia-Fellah, Celine Bressollette- Bodin, Fanny Rialland, Marianne Coste-Burel, Sameh Ayari, Jacques Delaunay, MD, Valerie Horvais, Jean-Luc Harousseau, Mohamad Mohty, MD, PhD, Berthe-Marie Imbert-Marcille

Blood (2008) 112 (11): 1148.

https://doi.org/10.1182/blood.V112.11.1148.1148

Published: 2008

NARROW

Antibody Response after One and/or Two Doses of BNT162b2 Anti- Sars-Cov-2 mRNA Vaccine in Patients Treated By CAR T-Cells Therapy

Sars-Cov-2 T-Cell Response in Allogeneic Hematopoietic Stem Cell Recipients Following Two Doses of BNT162b2 Vaccine

Interest of a Third Dose of BNT162b2 Anti- Sars-Cov-2 mRNA Vaccine in Allogeneic Hematopoietic Stem-Cells Recipients

Profound B-Cell Lymphopenia Is a Major Factor Predicting Poor Humoral Response after BNT162b2 mRNA Sars-Cov-2 Vaccines in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

Prognostic Value of Lymphopenia and Lymphocytosis after Peripheral Blood Haplo-Identical Stem Cell Transplantation

Post-Transplant Cyclophosphamide (PTCY) Versus Anti-Thymoglobulin (ATG) As Part of the Gvhd Prophylaxis for Fludarabine/Clofarabine/Busulfan Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT): Influence on Early Outcomes

Long-Lasting HHV-6 Reactivation and Immune Recovery In Adult Long-Survivors After Umbilical Cord Blood (UCB) Allo-SCT: A Comparison With PBSC As Stem-Cell Source

Prospective Comparison Of Five Viral Infections (HHV6, CMV, EBV, ADV, BKv) After Umbilical Cord Blood (UCB) Vs PBSC Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation (allo-SCT) In Adults

Higher HHV-6 Reactivation After Cord Blood Allo-SCT Is Not Related to HHV-6 Cell Receptor CD46 Expression

A Scoring System Predictive of Extensive Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Stem Cell Transplantation (allo-SCT)

Epstein Barr Virus (EBV) Reactivation After Reduced Intensity Conditioning (RIC) Allogeneic Hematopoietic Stem Cell Transplantation

Epstein Barr Virus (EBV) Reactivation After Reduced Intensity Conditioning (RIC) Unrelated Umbilical Cord Blood Transplantation (UCBT)

Features of Herpesviruses (CMV, EBV, HHV6) Infections and Immune Reconstitution after Allogeneic Stem Cell Transplantation (allo-SCT) Using Alternative Donors: Comparison Between Matched Unrelated Donors (MUD) and Cord Blood (CB) as Stem Cell Source.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only